You are here

  • Home
  • Archive
  • Volume 73, Issue 11
  • Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, the N…

Citation Tools

Article menu
Download PDFPDF
Clinical and epidemiological research
Extended report
Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, the NEO-RACo trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Rantalaiho V, Kautiainen H, Korpela M for the NEO-RACo Study Group, et al
Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, the NEO-RACo trial
Annals of the Rheumatic Diseases 2014;73:1954-1961.